Cargando…
Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2)
Olfactory dysfunction is common in COVID-19, and sudden-onset dysosmia is an early marker for wild-type SARS-CoV-2 infection. Over 10 000 mutations of SARS-CoV-2 have been registered, with variants of concern (VOC) under particular scrutiny. We report a telemedicine-based, multicentre, prospective c...
Autores principales: | Klimek, Ludger, Hagemann, Jan, Hummel, Thomas, Altundag, Aytug, Hintschich, Constantin, Stielow, Sabine, Bousquet, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095455/ https://www.ncbi.nlm.nih.gov/pubmed/35578676 http://dx.doi.org/10.1016/j.waojou.2022.100653 |
Ejemplares similares
-
Prevalence of acute olfactory dysfunction differs between variants of SARS-CoV-2—results from chemosensitive testing in wild type, VOC alpha (B.1.1.7) and VOC delta (B.1617.2)
por: Hintschich, Constantin A., et al.
Publicado: (2022) -
Author’s reply to the Letter to the Editor “The study of olfactory dysfunction in SARS-CoV-2 variants”
por: Hintschich, Constantin A., et al.
Publicado: (2022) -
Analysis of the Delta Variant B.1.617.2 COVID-19
por: Shiehzadegan, Shayan, et al.
Publicado: (2021) -
Implication of the emergence of the delta (B.1.617.2) variants on vaccine effectiveness
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022) -
The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant
por: Cai, Changjing, et al.
Publicado: (2021)